// App-Quantinova.ai

e15162 : Chemotherapy tolerance and oncologic outcomes in colorectal cancer (CRC) patients with and without inflammatory bowel disease (IBD).

Researchers

Presenter

  • Celina Ang

Principal Investigators

  • Umut Ozbek

  • Anuja Kriplani

  • Jordan Axelrad

  • Noam Harpaz

  • Jean-Frederic Colombel

  • Stephen H. Itzkowitz

  • Randall F. Holcombe

Medical Centers

  • Mt Sinai Medcl Ctr Tisch Cancer Inst, New York, NY

  • Icahn School of Medicine at Mount Sinai, New York, NY

  • Mount Sinai School of Medicine, New York, NY

  • Columbia University Medical Center, New York, NY

  • Mount Sinai Medical Center, New York, NY

  • Mount Sinai Hospital, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Inflammatory bowel disease

  • Colorectal Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved